+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07094750

Evaluating Treatment Intensity Choices for Less Fit Adults with Acute Myeloid Leukemia and Myeloid Neoplasms A Randomized Pilot Study

Led by Fred Hutchinson Cancer Center · Updated on 2026-10-19

50

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating treatment approaches for less fit adults diagnosed with acute myeloid leukemia AML or other high-grade myeloid neoplasms. This study aims to understand whether patients are willing to be randomly assigned to receive either higher-intensity or lower-intensity chemotherapy regimens. The need for this research arises from challenges in deciding treatment intensity for patients who may not tolerate aggressive therapy, especially given new treatment options and improved supportive care. Participants may receive higher-intensity therapy similar to a 73 chemotherapy regimen or lower-intensity therapy less intense than a 52 regimen, either as standard care or through investigational treatment trials. Depending on their willingness, patients are randomized to higher- or lower-intensity therapy, or they may choose their treatment intensity with their physician. Treatment continues as long as the disease does not progress or side effects are manageable. Throughout the study, participants undergo bone marrow assessments or blood sample collections as part of the evaluations. After completing treatment, patients are followed for up to 24 months with periodic check-ins. The main outcome assessed is the willingness of patients to accept randomization to different treatment intensities. This research is sponsored by Fred Hutchinson Cancer Center and seeks to improve treatment strategies for this patient group.

CONDITIONS

Brief Title

Randomization for the Identification of Best Treatment Intensity for Less Fit Adults With Acute Myeloid Leukemia and Myeloid Neoplasms

Research Team

J

Jacob Appelbaum, MD, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here